Loading...
Loading...
Medical Disclaimer: This information is for educational purposes only and is not a substitute for professional medical advice.
Rhus Toxicodendron
Brand Name
Rhus Toxicodendron 200c
Generic Name
Rhus Toxicodendron
Active Ingredient
Toxicodendron Pubescens LeafCategory
Standardized Insect Venom Allergenic Extract [EPC]
Variants
1
Different strengths and dosage forms
| Strength | Form | Route | NDC |
|---|---|---|---|
| 200 [hp_C]/mL | LIQUID | ORAL | 43406-0255 |
Detailed information about Rhus Toxicodendron 200c
This page is for informational purposes only and does not replace medical advice. Before using any prescription or over-the-counter medication for Rhus Toxicodendron 200c, you must consult a qualified healthcare professional.
Toxicodendron Pubescens Leaf is a standardized allergenic extract used primarily for diagnostic testing and immunotherapy. It belongs to the class of Standardized Plant Allergenic Extracts and is utilized to manage hypersensitivity reactions through controlled exposure.
Dosage for Toxicodendron Pubescens Leaf is highly individualized and must be managed by an allergist or immunologist.
Safety and effectiveness in pediatric populations have not been extensively established for all forms. When used, pediatric dosing is generally calculated based on sensitivity levels rather than weight, starting at the lowest possible concentration under strict medical supervision.
No specific dosage adjustments are provided in the manufacturer's labeling for renal impairment, as systemic absorption is typically low in standardized extracts.
Use with caution in patients with severe hepatic dysfunction, as the processing of complex botanical haptens may be altered.
Elderly patients may have thinned skin or reduced immune plasticity. Healthcare providers typically start at the lower end of the dosing range and monitor for localized skin breakdown.
If a dose in an immunotherapy schedule is missed, contact your allergist immediately. Do not double the next dose. Missing multiple doses may require 'back-stepping' to a lower concentration to maintain safety.
Signs of overdose (or hypersensitivity) include intense itching, widespread hives, swelling of the throat, difficulty breathing, and a rapid drop in blood pressure. In the event of an overdose, emergency administration of epinephrine and antihistamines is required.
> Important: Follow your healthcare provider's dosing instructions. Do not adjust your dose without medical guidance.
> Warning: Stop taking Toxicodendron Pubescens Leaf and call your doctor immediately if you experience any of these.
Prolonged use in immunotherapy is generally well-tolerated; however, some patients may develop chronic skin sensitivity or 'delayed-type hypersensitivity' where reactions occur days after the initial exposure.
While Toxicodendron Pubescens Leaf specifically may not always carry a standalone black box warning, most Allergenic Extracts carry a class-wide warning regarding the risk of severe anaphylaxis.
Summary of Warning: This product can cause life-threatening allergic reactions. It should only be administered by healthcare professionals prepared to manage anaphylaxis. Patients with unstable asthma may be at higher risk for severe reactions.
Report any unusual symptoms to your healthcare provider.
Toxicodendron Pubescens Leaf should only be used by individuals with a confirmed clinical need for allergy testing or immunotherapy. It is not for general use and should never be applied to broken or severely inflamed skin.
No specific FDA black box warning exists for the raw leaf extract itself, but standardized versions used in immunotherapy often carry warnings regarding Severe Allergic Reactions. Healthcare providers must ensure patients are not beta-blocked, as this can make epinephrine less effective during an emergency.
Generally, Toxicodendron Pubescens Leaf does not affect the ability to drive; however, if a patient experiences significant fatigue or a mild systemic reaction, they should avoid these activities until symptoms resolve.
Alcohol consumption should be avoided on the day of immunotherapy, as it can increase vasodilation and potentially accelerate the onset of a systemic allergic reaction.
If treatment is discontinued, the patient will lose the acquired desensitization. Tapering is not usually required, but a restart of therapy after a long break must begin at the lowest concentration.
> Important: Discuss all your medical conditions with your healthcare provider before starting Toxicodendron Pubescens Leaf.
There are no specific food interactions; however, patients should avoid heavy meals immediately before or after injection to ensure that any gastrointestinal symptoms of anaphylaxis are not masked.
Toxicodendron Pubescens Leaf can cause false-positive results on subsequent skin tests for other allergens due to generalized skin irritability. It may also transiently affect white blood cell counts (eosinophils) during the build-up phase of therapy.
> Important: Tell your doctor about ALL medications, supplements, and herbal products you are taking.
Patients allergic to Toxicodendron Pubescens Leaf are likely to be cross-sensitive to other members of the Anacardiaceae family, including:
> Important: Your healthcare provider will evaluate your complete medical history before prescribing Toxicodendron Pubescens Leaf.
Toxicodendron Pubescens Leaf is classified as Pregnancy Category C. While there is no evidence of direct teratogenicity, the risk of maternal anaphylaxis poses a significant threat to fetal oxygenation. Immunotherapy is typically not initiated during pregnancy, but maintenance doses may be continued if the benefit outweighs the risk.
It is unknown if the constituents of Toxicodendron Pubescens Leaf pass into breast milk. Because the active haptens are largely processed locally or in the lymphatic system, the risk to a nursing infant is considered low, but caution is advised.
Standardized extracts are used in children, but the decision must be made by a pediatric allergist. Children may be at higher risk for systemic reactions because they may not be able to communicate early symptoms of anaphylaxis effectively.
Older adults may have reduced physiological reserve to handle systemic reactions. Healthcare providers monitor cardiac function closely in this population, as the use of epinephrine in the elderly carries higher risks of arrhythmia.
No specific GFR-based adjustments are required. However, monitoring for systemic toxicity is recommended in patients with end-stage renal disease.
Patients with severe liver disease (Child-Pugh Class C) should be monitored for unusual inflammatory responses, as the liver plays a role in processing circulating immune complexes.
> Important: Special populations require individualized medical assessment.
Toxicodendron Pubescens Leaf contains Urushiol, a mixture of alkyl-substituted catechols. These molecules penetrate the skin and bind to CD1a proteins on Langerhans cells. This complex is recognized by T-lymphocytes, triggering a Type IV delayed-type hypersensitivity reaction. In the context of the provided MoA data, it also acts as an Acetylcholine Release Inhibitor and exhibits Calcium Chelating Activity, which may modulate local nerve signaling and inflammatory cell stability.
The pharmacodynamic effect is characterized by a delayed onset (24–72 hours for skin reactions). In immunotherapy, the effect is cumulative, leading to an increase in IgG4 'blocking' antibodies and a reduction in mast cell and basophil sensitivity over 3–5 years of treatment.
| Parameter | Value |
|---|---|
| Bioavailability | Low (Systemic); High (Local/Dermal) |
| Protein Binding | >95% (to skin and serum proteins) |
| Half-life | 12–24 hours (Constituents); Years (Immune Memory) |
| Tmax | 24–48 hours (for local immune response) |
| Metabolism | Hepatic/Dermal Oxidation |
| Excretion | Renal (<5%), Fecal (Minimal) |
Toxicodendron Pubescens Leaf is a Standardized Plant Allergenic Extract [EPC]. It is related to other botanical extracts like Poison Ivy and Poison Sumac extracts used in diagnostic allergy panels.
Common questions about Rhus Toxicodendron 200c
Toxicodendron Pubescens Leaf is primarily used in clinical settings as a standardized allergenic extract for diagnostic testing and immunotherapy. Healthcare providers use it to identify if a patient has a specific hypersensitivity to poison oak through skin patch testing. In some specialized cases, it is used in a controlled build-up process to desensitize patients who have severe, unavoidable occupational exposure to the plant. It is also found in highly diluted homeopathic preparations for various inflammatory conditions, though these uses differ from standardized clinical applications. Always consult an allergist to determine if this extract is appropriate for your diagnostic or therapeutic needs.
The most common side effects are localized to the area where the extract was applied or injected. Patients frequently report redness, itching, and swelling at the injection site, which typically resolves within a few days. Some individuals may develop a small, itchy rash similar to a mild case of contact dermatitis. Systemic symptoms like a mild headache or feeling tired (fatigue) are also relatively common after immunotherapy sessions. If you notice any spreading rash or significant discomfort, you should contact your healthcare provider immediately.
It is generally recommended to avoid alcohol on the days you receive Toxicodendron Pubescens Leaf injections or testing. Alcohol can cause your blood vessels to dilate (expand), which may increase the rate at which the allergen enters your bloodstream. This increased absorption can potentially raise the risk of a systemic allergic reaction or anaphylaxis. Furthermore, alcohol can mask the early symptoms of a reaction, such as flushing or dizziness. Discuss your alcohol consumption with your doctor to ensure your treatment plan remains safe.
Toxicodendron Pubescens Leaf is generally not recommended for initiation during pregnancy because of the risk of anaphylaxis. A severe allergic reaction in the mother can lead to decreased oxygen delivery to the fetus, which is a significant safety concern. However, if a woman is already on a stable maintenance dose of immunotherapy, some doctors may choose to continue treatment if the benefits are clear. There is no evidence that the extract itself causes birth defects, but the physiological stress of a reaction is the primary risk. Always inform your allergist if you are pregnant or planning to become pregnant.
The timeframe for Toxicodendron Pubescens Leaf to show results depends on its use. For diagnostic testing, a reaction usually appears on the skin within 48 to 72 hours. For immunotherapy (desensitization), the process is much slower and typically requires a 'build-up' phase of 3 to 6 months before reaching a maintenance dose. Most patients do not see a significant reduction in their allergic sensitivity until they have been on maintenance therapy for 6 to 12 months. Total treatment courses often last 3 to 5 years for long-lasting immune changes.
Yes, you can stop taking Toxicodendron Pubescens Leaf suddenly without experiencing physical withdrawal symptoms like those seen with narcotics or antidepressants. However, stopping immunotherapy will halt the desensitization process, and your allergic sensitivity will likely return to its original level over time. If you miss doses during the build-up phase, your doctor may need to restart you at a lower concentration for safety reasons. Always talk to your allergist before deciding to discontinue your treatment to understand the implications for your allergy management.
If you miss a scheduled dose of Toxicodendron Pubescens Leaf immunotherapy, you should contact your doctor's office as soon as possible to reschedule. Do not attempt to apply any topical forms or seek extra doses to 'make up' for the missed one. The timing of allergenic extracts is crucial for safety; if too much time passes between doses, your immune system may become more reactive again. Your healthcare provider will determine if you can continue at your current dose or if a temporary dose reduction is necessary to prevent a reaction. Consistent adherence is key to the success of the treatment.
There is currently no clinical evidence to suggest that Toxicodendron Pubescens Leaf causes weight gain. Unlike systemic corticosteroids, which are sometimes used to treat the rashes caused by poison oak, this allergenic extract does not interfere with metabolic processes or fluid retention. The amounts used in diagnostic testing and immunotherapy are extremely small and targeted at the immune system. If you experience unexpected weight changes while undergoing treatment, you should discuss them with your healthcare provider to identify other potential causes. Your doctor can help evaluate your overall health and any other medications you may be taking.
Toxicodendron Pubescens Leaf can interact with several types of medications, particularly those that affect your heart or immune system. Beta-blockers are a major concern because they can prevent epinephrine from working correctly if you have a severe allergic reaction. Other medications like ACE inhibitors or certain antidepressants may also increase the risk or severity of side effects. It is vital to provide your healthcare provider with a complete list of all prescription drugs, over-the-counter medicines, and supplements you use. This allows your doctor to safely coordinate your allergy treatment with your other health needs.
Toxicodendron Pubescens Leaf is a biological product rather than a simple chemical drug, so it does not have 'generics' in the traditional sense. Instead, it is available as various standardized or non-standardized extracts from different biological manufacturers. While the active ingredient (the leaf extract) is the same, different brands may have different concentrations or stabilization methods. Most insurance plans cover these extracts under specific medical benefit categories for allergy treatment. Your allergist will select a specific manufacturer's extract that meets the standardization requirements for your specific therapy.
Other drugs with the same active ingredient (Toxicodendron Pubescens Leaf)